NDC80 and cancer: Here we report the discovery and characteristics of a novel anti-mitotic compound VTT-006, a 1,2-disubstituted-tetrahydro-beta-carboline derivative, that interferes with Hec1-microtubule interaction in vitro and perturbs normal mitosis leading to growth suppression in cultured cancer cells.